Search

OmniCellar

About

Real-time biosensing for drug discovery

OmniCellar is a high-precision platform that combines 3D bioprinted organ-on-a-chip models with aptamer-based electrochemical sensors to monitor tissue health in real time. These sensors track glucose and lactic acid levels every 30 minutes for up to a week, revealing disease progression and drug effects with exceptional accuracy. By replacing destructive lab testing with dynamic metabolic readouts, OmniCellar helps researchers predict treatment outcomes more reliably, reducing development costs and accelerating therapies for chronic and age-related diseases

Team

  • Sadman Sakib

    Sadman Sakib

    McMaster University

    Sadman is a postdoctoral fellow at McMaster University, leveraging a unique multidisciplinary background to tackle challenges in medical diagnostics. Born in Dhaka, Bangladesh and raised in Toronto, Canada, he earned a B.Eng in Electrical Engineering followed by a Ph.D. in Engineering Physics from McMaster. His research bridges techniques from materials science, electronics, biotechnology, and AI to engineer advanced solutions for biosensing. He has designed novel nanomaterials, biochemical assays, and portable electronics for detection of disease biomarkers, and infectious agents. This expertise is embodied in his latest innovation, the OmniCellar platform, which integrates organ-on-a-chip systems with biosensors for real-time metabolic monitoring.more

  • Anushree Chakravarty
  • Dr. Leyla Soleymani

    McMaster University

    Supervising Professormore


Similiar Projects

C-scope

C-scope

Delft University of Technology – TU Delft

AI-assisted cervical screening for early cancer detection in low-resource settings

Duco

Duco

Imperial College London

Needle-free wearable for real-time hormone monitoring

EndoMark

EndoMark

The Pennsylvania State University

At-home menstrual test for early endometriosis detection

GumAI

GumAI

The University of Hong Kong

Smartphone-based AI for early gum disease detection